Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used extensively by researchers to research cancer signaling pathways and functioning. Recombinant immune checkpoint such as PD-1/PD-L1 Inhibitor 1 and PD-1/PD-L1 Inhibitor 2, which directly targets programmed death-1 (PD-1) and programmed death ligand-1 and 2 (PD-L1) are used for research purposes. Moreover, proteins such as CD226, CD40 Ligand/TRAP, and Human CellExp CTLA4/CD152 are extensively used in cancer therapies research.
Market Dynamics
Increasing demand for recombinant proteins for basic research has supported growth of recombinant protein market. Manufacturers are involved in recombinant protein product innovation in order to improve research outcomes along with improvements in other areas such as expression techniques, and protein purification techniques, which compliments growth of the recombinant protein market. The market is expected to gain significant growth, owing increasing adoption of biologics and biosimilars, which will in turn impact recombinant proteins market, along with rising prevalence of chronic diseases such as cancer. Furthermore, availability of wide number of innovative recombinant proteins from various sources such as human and animal, lack of suitable alternative for basic protein related therapies research, and increasing demand for biological products is expected to fuel growth of the market
Key features of the study:
This report provides in-depth analysis of recombinant protein market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global recombinant protein market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Crown Bioscience, Inc., ProSpec Tany TechnoGene, Ltd., BPS Bioscience, Inc., Sigma Aldrich Company Ltd., Novoprotein Scientific, PeproTech, Inc., Feldan Bio, Inc., BioVision, Inc., HumanZyme, Inc., and GenScript Biotech Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global recombinant protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the recombinant protein market
Detailed Segmentation:
Global Recombinant Protein Market, By Product Type:
Hormones
Growth Factor
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Global Recombinant Protein Market, By Application:
Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others
Global Recombinant Protein Market, By End User:
Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations
Others
Global Recombinant Protein Market, By Geography:
North America
By Product Type:
Hormones
Growth Factor
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
By Application:
Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others
By End User:
Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations
Others
By Country:
U.S.
Canada
Europe
By Product Type:
Hormones
Growth Factor
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
By Application:
Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others
By End User:
Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Hormones
Growth Factor
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
By Application:
Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others
By End User:
Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
Hormones
Growth Factor
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
By Application:
Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others
By End User:
Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations
Others
By Country:
Brazil
Mexico
Rest of Latin America
Middle East
By Product Type:
Hormones
Growth Factor
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
By Application:
Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others
By End User:
Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Hormones
Growth Factor
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
By Application:
Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others
By End User:
Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations
Others
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Crown Bioscience, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
ProSpec Tany TechnoGene, Ltd.
BPS Bioscience, Inc.
Sigma Aldrich Company Ltd.
Novoprotein Scientific
PeproTech, Inc.
Feldan Bio, Inc.
BioVision, Inc.
HumanZyme, Inc.
GenScript Biotech Corporation
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Product Type
? Market Snippet, By Application
? Market Snippet, By End User
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o PEST Analysis
o PORTER's Analysis
4. Global Recombinant Protein Market, By Product Type, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Hormones
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Growth Factor
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Cytokines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Plasma Protein Factor
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Recombinant Metabolic Enzymes
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Immune Checkpoint Regulators
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
5. Global Recombinant Protein Market, By Application, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Drug Discovery & Development
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Biopharmaceutical Production
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Basic Research
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
6. Global Recombinant Protein Market, By End User, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Biopharmaceutical Companies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Academic & Research Institutes
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Contract Research Organizations
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
7. Global Recombinant Protein Market, By Region, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2016-2025
o North America
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? U.K.
? Germany
? Italy
? France
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? China
? India
? Japan
? ASEAN
? Australia
? South Korea
? Rest of APAC
o Latin America
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? Brazil
? Mexico
? Rest of Latin America
o Africa
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? Central Africa
? South Africa
? North Africa
o Middle East
? Market Size and Forecast, By Product Type, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? GCC
? Israel
? Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Crown Bioscience, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? ProSpec Tany TechnoGene, Ltd.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? BPS Bioscience, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Sigma Aldrich Company Ltd.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Novoprotein Scientific
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? PeproTech, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Feldan Bio, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? BioVision, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? HumanZyme, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? GenScript Biotech Corporation
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 39 market data tables and 40 figures on "Recombinant Protein Market - Global forecast to 2025".
